期刊文献+

药物性肝损害36例临床分析 被引量:3

Preliminary clinical study on drug induced liver injury in 36 patients
下载PDF
导出
摘要 目的提高对药物性肝损害诊断的准确性。方法对36例药物性肝损害(DILI)患者的临床资料进行回顾性分析。结果在药物性肝损害患者中,中药9例(25%),居首位,其次为抗生素7例(19.4%)和抗结核药物6例(16.7%)。临床主要表现为皮肤巩膜黄染(55.6%)、乏力(47.2%)、纳差(44.4%);其中肝细胞损伤型22.2%,胆汁淤积型66.7%,混合型11.1%。结论药物性肝损害是临床常见病,应重视中药的肝毒性,提高对药物性肝损害的识别,尤其应重视胆汁淤积型肝病的鉴别诊断。 Objective To improve the diagnosis on drug induced liver injury (DILI). Methods The retrospective study on the clinical data of 36 cases of DILI in the last five years of our hospital. Results A variety of drugs, including traditional chinese medieine (25% of our total cases), antimierobial agents (19.4%) and tubereulostatic agents (16.7%). The main clinical manifestations of it were jaundice (55.6%), fatigue (47.2%), and nausea (44.4%). With clinical manifestations 22.2% of patients were classified as hepatocelluar type, 66.7% as cholestatic type and 11.1% as mixed type. Conclusion The drugs that can cause liver injury should be used carefully.
出处 《中国现代医药杂志》 2008年第10期60-62,共3页 Modern Medicine Journal of China
关键词 药物性 肝毒性 肝炎 诊断 Drug-induced Hepatotoxicity Hepatitis Diagnosis
  • 相关文献

参考文献12

  • 1[1]Kane J A,Kane S P,Jain S.Hepatitis induced by Traditional herbs:possible toxic components[J].Gut,1995,36:146-147
  • 2[2]Ehrmann J,Strojil J.Current concepts and morphological aspects of drug induced liver injury.Cesk Patol,2008,44(1):4-7
  • 3[3]Maria VA,Victorino RM.Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis.Hepatology,1997,26:664-669
  • 4[4]Danan G,Benichou C.Causality assessment of adverse reactions to drugs.A novel method based on the conclusions of international consensus meetings:application to drug-induced liver injuries.J Clin Epidemiol,1993,46:1323-1330
  • 5[5]Teschke R.Drug-induced liver diseases.Z Gastroenterel.2002,4(5):305-26
  • 6[6]Buratti S,Lavine JE.Drug and liver:,advances in metabolism,toxicity,and therapeutics.Curt Opin Pediatr,2002,14:601-607
  • 7[7]Holt MP,Ju C.Mechanisms of drug-induced liver injury.AAPS J,2006,8(1):E48-54
  • 8陈成伟.药物性肝病的发病机制及诊治[J].肝脏,2007,12(4):297-302. 被引量:53
  • 9余卫业,袁静,戴炜,袁虹,李少珍.药物性肝炎152例临床分析[J].中国医师进修杂志,2006,29(2):52-53. 被引量:21
  • 10[10]Andrade RJ,Lucena MI,Fernandez MC,et al.Drug-induced liver injury:an analysis of 461 incidences submitted to the Spa-nish registry over a 10-year period.Gastroenterelogy,2005,129:512-521

二级参考文献20

  • 1黄伟,黄汉平.53例结核药致重症药物性肝炎的临床分析[J].数理医药学杂志,2004,17(4):334-334. 被引量:20
  • 2陈灏珠.实用内科学(第11版)[M].北京:人民卫生出版社,2001.1785.
  • 3陈成伟.细胞色素P450遗传多态性意义及其基因型与表型的检测[A].见:陈成伟 主编.药物与中毒性肝病 第1版[C].上海:上海科学技术出版社,2002.312-327.
  • 4Kaplovitz N, Drug induced liver disorders:implication for drug development and regulation. Drug Saf,2001,24:483 - 490.
  • 5丰田隆谦,上野义之.Rifampicin诱导体の临床治疗效果と副作用.日本临谨慎床,2000,58:376-382.
  • 6陈成伟,姜丽静.草药和植物的肝脏毒性.见:姚光弼,主编.临床肝脏病学.上海:上海科学技术出版社,2004.528-537.
  • 7Lee WM.Drug-induced hepatotoxicity.N Engl J Med,2003,349:474-485.
  • 8Lee WM.Acetaminophen and the U.S.acute liver failure study group:lowering the risks of hepatic failure.Hepatology,2004,40:6-9.
  • 9Evans DC,Watt AP,Nicoll-Grifith DA,Baillie TA.Drug-protein adducts:an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development.Chem Res Toxicol,2004,17:3-16.
  • 10Park BK,Kitteringham NR,Maggs JL,Pirmohamed M,Williams RP.The role of metabolic activation in drug-induced hepatotoxicity.Annu Rev Pharmacol Toxicol,2005,45:177-202.

共引文献72

同被引文献13

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部